Sanofi (SNY) FCF Margin (2009 - 2026)

Sanofi has disclosed FCF Margin across 10 years of filings, most recently posting 23.3% for Q1 2026.

• FCF Margin for Q1 2026 came in at 23.3%, up 126.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 47.07% (down 292.0% YoY), and the FY2025 annual result was 16.53%, up 220.0% from the prior year.
• FCF Margin came in at 23.3% for Q1 2026 at Sanofi, up from 112.44% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 152.8% in Q4 2024 to a low of 112.44% in Q4 2025.
• The 5-year median for FCF Margin is 22.95% (2025), against an average of 27.72%.
• Across the five-year window, FCF Margin soared 12697 bps in 2024 and tumbled 26524 bps in 2025, its largest moves.
• Sanofi's FCF Margin stood at 102.31% in 2022, then tumbled by 75 bps to 25.83% in 2023, then surged by 492 bps to 152.8% in 2024, then sank by 174 bps to 112.44% in 2025, then jumped by 121 bps to 23.3% in 2026.
• The last three FCF Margin figures came in at 23.3% (Q1 2026), 112.44% (Q4 2025), and 22.6% (Q3 2025), per Business Quant data.